These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9147611)

  • 21. Apoptotic mechanism of paclitaxel-induced cell death in human head and neck tumor cell lines.
    Hsiao JR; Leu SF; Huang BM
    J Oral Pathol Med; 2009 Feb; 38(2):188-97. PubMed ID: 19200178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spheroid-based 3-dimensional culture models: Gene expression and functionality in head and neck cancer.
    Schmidt M; Scholz CJ; Polednik C; Roller J
    Oncol Rep; 2016 Apr; 35(4):2431-40. PubMed ID: 26797047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinoic acid inhibition of a head and neck multicellular tumor spheroid model.
    Sacks PG; Oke V; Vasey T; Lotan R
    Head Neck; 1989; 11(3):219-25. PubMed ID: 2722497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxytocin inhibits head and neck squamous cell carcinoma cell migration by early growth response-1 upregulation.
    Kim J; Kang SM; Lee HJ; Choi SY; Hong SH
    Anticancer Drugs; 2017 Jul; 28(6):613-622. PubMed ID: 28452807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multicellular tumor spheroid model of cellular immunity against head and neck cancer.
    Sacks PG; Taylor DL; Racz T; Vasey T; Oke V; Schantz SP
    Cancer Immunol Immunother; 1990; 32(3):195-200. PubMed ID: 2289213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential of a Cetuximab-based radioimmunotherapy combined with external irradiation manifests in a 3-D cell assay.
    Ingargiola M; Runge R; Heldt JM; Freudenberg R; Steinbach J; Cordes N; Baumann M; Kotzerke J; Brockhoff G; Kunz-Schughart LA
    Int J Cancer; 2014 Aug; 135(4):968-80. PubMed ID: 24615356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiosensitivity, repair capacity, and stem cell fraction in human soft tissue tumors: an in vitro study using multicellular spheroids and the colony assay.
    Stuschke M; Budach V; Klaes W; Sack H
    Int J Radiat Oncol Biol Phys; 1992; 23(1):69-80. PubMed ID: 1572832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic interaction of natural human tumor necrosis factor-alpha/natural human interferon-alpha mixture alone and in combination with cisplatin against head and neck laryngeal squamous carcinoma multicellular tumor spheroids.
    Kohno N; Ohnuma T; Kawaida M; Ichikawa G
    Auris Nasus Larynx; 1993; 20(1):53-62. PubMed ID: 8323491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential gene expression in a paclitaxel-resistant clone of a head and neck cancer cell line.
    Schmidt M; Schler G; Gruensfelder P; Hoppe F
    Eur Arch Otorhinolaryngol; 2006 Feb; 263(2):127-34. PubMed ID: 16380805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proliferation, migration and invasion of human glioma cells exposed to paclitaxel (Taxol) in vitro.
    Terzis AJ; Thorsen F; Heese O; Visted T; Bjerkvig R; Dahl O; Arnold H; Gundersen G
    Br J Cancer; 1997; 75(12):1744-52. PubMed ID: 9192976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (PA390).
    Forastiere AA; Shank D; Neuberg D; Taylor SG; DeConti RC; Adams G
    Cancer; 1998 Jun; 82(11):2270-4. PubMed ID: 9610709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraarterial chemotherapy with polyoxyethylated castor oil free paclitaxel, incorporated in albumin nanoparticles (ABI-007): Phase I study of patients with squamous cell carcinoma of the head and neck and anal canal: preliminary evidence of clinical activity.
    Damascelli B; Cantù G; Mattavelli F; Tamplenizza P; Bidoli P; Leo E; Dosio F; Cerrotta AM; Di Tolla G; Frigerio LF; Garbagnati F; Lanocita R; Marchianò A; Patelli G; Spreafico C; Tichà V; Vespro V; Zunino F
    Cancer; 2001 Nov; 92(10):2592-602. PubMed ID: 11745194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paclitaxel-induced apoptotic changes followed by time-lapse video microscopy in cell lines established from head and neck cancer.
    Pulkkinen JO; Elomaa L; Joensuu H; Martikainen P; Servomaa K; Grenman R
    J Cancer Res Clin Oncol; 1996; 122(4):214-8. PubMed ID: 8601573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of drug transporters' significance for multidrug resistance in head and neck squamous cell carcinoma.
    Theile D; Ketabi-Kiyanvash N; Herold-Mende C; Dyckhoff G; Efferth T; Bertholet V; Haefeli WE; Weiss J
    Head Neck; 2011 Jul; 33(7):959-68. PubMed ID: 20737486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of cyclin D1 correlates with sensitivity to cisplatin in squamous cell carcinoma cell lines of the head and neck.
    Akervall J; Kurnit DM; Adams M; Zhu S; Fisher SG; Bradford CR; Carey TE
    Acta Otolaryngol; 2004 Sep; 124(7):851-7. PubMed ID: 15484403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effectiveness of taxol in head-neck tumors].
    Schalhorn B
    Med Klin Suppl; 1993 Nov; 2():15. PubMed ID: 7904716
    [No Abstract]   [Full Text] [Related]  

  • 37. Taxol and taxotere in bladder cancer: in vitro activity and urine stability.
    Rangel C; Niell H; Miller A; Cox C
    Cancer Chemother Pharmacol; 1994; 33(6):460-4. PubMed ID: 7907952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intensive radiation therapy concurrent with up to 7-week continuous-infusion paclitaxel for locally advanced solid tumors: phase I studies.
    Rosenthal DI; Okani O; Truelson JM; Fathallah-Shaykh H; Vuitch FM; Gazdar AF; Griener J; Landay M; Mendelsohn D; Tourville J; Hamilton L; Orr KY; McWhorter J; Carbone DP
    Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-81-S2-84. PubMed ID: 9045344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction paclitaxel in previously untreated, resectable, advanced squamous cell carcinomas of head and neck.
    Grecula JC; Smith RE; Rhoades CA; Sharma P; Agrawal A; Zhang H; Allen J; Goldman FP; Young D; Schuller DE
    Cancer; 2000 Dec; 89(12):2587-96. PubMed ID: 11135220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro.
    Sun Z; Hu W; Xu J; Kaufmann AM; Albers AE
    Int J Oncol; 2015 Oct; 47(4):1339-50. PubMed ID: 26323460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.